Lv5
836 积分 2026-05-05 加入
Nipocalimab and other FcRn blockers in neuromuscular disorders
10天前
已完结
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
18天前
已完结
Unnatural Amino Acids: Strategies, Designs, and Applications in Medicinal Chemistry and Drug Discovery
20天前
已完结
Development of Macrocyclic Peptide-Based Proteasome Inhibitors with Enhanced Blood-Brain Barrier Penetration for Treating Brain Neoplasms
29天前
已完结
HighPlay: Cyclic Peptide Sequence Design Based on Reinforcement Learning and Protein Structure Prediction
29天前
已完结
MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment
29天前
已完结
New Oral PCSK9 Inhibitor: “MK-0616”
29天前
已完结
Synthesis of a Complex and Highly Potent PCSK9 Inhibitor
29天前
已完结
YN1548: A novel small-molecule agonist of human glucagon-like peptide-1 receptor for the treatment of type 2 diabetes mellitus and obesity
2个月前
已完结
Toxicology profile of a novel GLP-1 receptor biased agonist-SAL0112 in nonhuman primates
2个月前
已完结
皖公网安备34019202002308
